Literature DB >> 3965676

Behavior problems and social competence in girls with true precocious puberty.

W A Sonis, F Comite, J Blue, O H Pescovitz, C W Rahn, K D Hench, G B Cutler, D L Loriaux, R P Klein.   

Abstract

We report a controlled standardized behavioral assessment of 33 girls with true precocious puberty using the Child Behavior Checklist. Although a majority of the girls were reported not to have behavior problems, many were reported to have a dysphoric adjustment to their condition. Twenty-seven percent of the girls with true precocious puberty scored greater than 2 SD above the mean on the Total Behavior Problem scale 10 times the expected prevalence rate. They also scored significantly higher (P less than 0.01) than matched controls on both the internalizing or "overcontrolled symptom" and externalizing or "undercontrolled symptom" scales. Forty-eight percent scored greater than 2 SD above the mean on the Social Withdrawal scale. The high prevalence of reported problem behaviors in this sample may be related directly or indirectly to the precocious maturation mediated by biologic, psychologic, social, and environmental variables. Although elevated levels of sex steroids may directly contribute to increased aggressive and hyperactive behaviors, they may also be modified by social and environmental factors.

Entities:  

Mesh:

Year:  1985        PMID: 3965676     DOI: 10.1016/s0022-3476(85)80489-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Recent Advances in the Treatment of Isosexual Precocious Puberty: Identifying all the problems.

Authors:  A K Leung; R G McArthur
Journal:  Can Fam Physician       Date:  1991-12       Impact factor: 3.275

2.  IV. Growth Failure in Institutionalized Children.

Authors:  Dana E Johnson; Megan R Gunnar
Journal:  Monogr Soc Res Child Dev       Date:  2011-12

3.  One-Year Follow-Up of Girls with Precocious Puberty and Their Mothers: Do Psychological Assessments Change over Time or with Treatment?

Authors:  Melissa J Schoelwer; Kelly L Donahue; Paula Didrick; Erica A Eugster
Journal:  Horm Res Paediatr       Date:  2017-09-19       Impact factor: 2.852

4.  The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty.

Authors:  S L Drop; R J Odink; C Rouwé; B J Otten; M W Van Maarschalkerweerd; M Gons; A Bot; M Meradji; F H de Jong; F M Slijper
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

Review 5.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

6.  Pubertal pathways in girls enrolled in a contemporary british cohort.

Authors:  Krista Yorita Christensen; Mildred Maisonet; Carol Rubin; Adrianne Holmes; W Dana Flanders; Jon Heron; Jean Golding; Michael A McGeehin; Michele Marcus
Journal:  Int J Pediatr       Date:  2010-06-22

Review 7.  A critical review of the empirical literature on the relation between anxiety and puberty.

Authors:  Laura E Reardon; Ellen W Leen-Feldner; Chris Hayward
Journal:  Clin Psychol Rev       Date:  2008-09-19

8.  Abnormal timing of menarche in survivors of central nervous system tumors: A report from the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong; John A Whitton; Amar Gajjar; Larry E Kun; Eric J Chow; Marilyn Stovall; Wendy Leisenring; Leslie L Robison; Charles A Sklar
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

9.  Psychosocial aspects in girls with idiopathic precocious puberty.

Authors:  Eun Young Kim; Moon In Lee
Journal:  Psychiatry Investig       Date:  2012-01-09       Impact factor: 2.505

10.  Body image in adolescents with disorders of steroidogenesis.

Authors:  Cong Ning; Liza Green-Golan; Constantine A Stratakis; Ellen Leschek; Ninet Sinaii; Elizabeth Schroth; Monique Ernst; Deborah P Merke
Journal:  J Pediatr Endocrinol Metab       Date:  2008-08       Impact factor: 1.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.